Provepharm issued a recall of its Phenylephrine hydrochloride injection from lot number 24020027 due to the discovery of black particulate matter in a vial. The affected lot, with an expiration date of December 2025, was distributed nationwide to hospitals and…

As the new year begins, gyms are crowded, dietitians' schedules are packed and dental chairs are filled — signs that Americans are embracing their New Year's resolutions to focus on health. Alongside these personal commitments, many are also facing important…

Here are nine new shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. 

The National Community Pharmacists Association has told CMS that more than 90% of independent pharmacies may choose to stop stocking drugs included in the Medicare Drug Price Negotiation Program due to financial losses that could threaten their viability. 

An increasing number of health systems are bringing pharmacy benefit manager services in house, a trend driven by a goal to reduce prescription drug costs, improve transparency and have more control over patient care. 

AbbVie has entered a collaboration with Neomorph to develop molecular glue degraders for oncology and immunology. 

The AIDS Healthcare Foundation won a legal battle against pharmacy benefit manager Prime Therapeutics LLC in an arbitration ruling on Jan. 17.

As norovirus cases increase across the U.S., Moderna is conducting a phase 3 trial with 25,000 participants to test its experimental vaccine, CNBC reported. 

The core mission of healthcare technology is to bring simplicity and safety to patients, providers, and staff. Yet in the realm of compliance, the landscape grows increasingly complex. Compliance workflows including those for diversion surveillance, patient privacy monitoring, and 340B…

As the abortion pill mifepristone faces an unclear future in some states, researchers have identified a drug with a similar chemical profile that could serve as an effective alternative.